Industry Watch
Abstract
CyGenics and MCRI Collaborate in Stem Cell Expansion Trials.
Bionomics Collaborates with Louisiana State University in Cancer Gene Therapy.
Concerns over Impact of FTA on Pharma Industry.
Antisense Therapeutics' MS Drug Enters Phase 2 Clinical Trials.
Cancer Vac Commences Phase II Trial for Ovarian Cancer Treatment.
Regenera Receives Human Ethics Approval for Visagen Phase III Trial.
Relenza Dispute between Biota & GSK.
Rockeby Biomed Test SysCan3 on Newborns in US.
AstraZeneca Outlines Plan for Expansion of India-based Operations.
Ranbaxy Seeking New CRO for Generic AIDS Drugs.
Indian Drug Exports Likely to be Affected by New US Initiatives.
Acyte and Serono Working on Cell Expression Technology.
Takeda Withdraws from Five Joint Ventures.
Kyowa and AnalytiCon Succeeded on Molecule Search.
Lion Takes On Chugai's OTC Drugs Business.
Kyorin and Merck Collaborate in Antibiotics Research.
Fujisawa's New Formulation Facilities Completed.
CordLife Secured US Defense Contract.
- CyGenics
- MCRI
- Stem Cell Expansion Trials
- Bionomics
- Louisia State University
- Cancer Gene Therapy
- Impact of FTA
- Pharma Industry
- Antisense Therapeutics' MS Drug
- Phase 2 Clinical Trials
- Cancer Vac
- Phase 2 Trial
- Visagen
- Phase 3 Trial
- Relenza Dispute
- Biota & GSK
- Rockeby
- Biomed Test
- SysCan3
- Newborn in US
- AstraZeneca Outlines
- Expansion of India-based Operation
- Ranbaxy
- New CRO
- Generic AIDS Drug
- Indian Drug Export
- New US Initiatives
- Acyte
- Serono
- Cell Expression Technology
- Takeda
- Five Joint Venture
- Kyowa
- AnalytiCon
- Molecule Search
- Lion
- Chugai's OTC Drug Business
- Kyorin
- Merck
- Antibiotics Research
- Fujisawa
- New Formulation Facilities Completed
- CordLife
- US Defense Contract
